高级检索
复方威爪龙制剂抗移植性肿瘤的实验研究[J]. 中国药科大学学报, 2000, (1): 46-48.
引用本文: 复方威爪龙制剂抗移植性肿瘤的实验研究[J]. 中国药科大学学报, 2000, (1): 46-48.
AntitumorEffect of Compound Weizl on Experimental Tumor[J]. Journal of China Pharmaceutical University, 2000, (1): 46-48.
Citation: AntitumorEffect of Compound Weizl on Experimental Tumor[J]. Journal of China Pharmaceutical University, 2000, (1): 46-48.

复方威爪龙制剂抗移植性肿瘤的实验研究

AntitumorEffect of Compound Weizl on Experimental Tumor

  • 摘要: 复方威爪龙制剂是根据临床抗癌验方应用现代药剂技术制备面而成的口服液和注射液,由白花蛇舌草(Oldenlandiadiffusa(Willd.)Roxd.)DGV VO WM (cLEMATISCHINENSISoSBECK),苓(Poriacocos(Schw.)Wolf),天花粉(TrichosantheskirlowiiMaxim.)TFFUQQ KFI WFXYK AJJ AX RN XED

     

    Abstract: Compound Weizl is a traditional Chinese medicine. It is mainly composed of Chinese medicinal plants of Wei Ling Xian ( Clematis chinensis Osbeck), Bai Hua She She Cao ( Oldenlandia diffusa (Willd.) Roxd )and Tian Hua Fen ( Trichosant

     

/

返回文章
返回